|
|
||||||||
inhibits human airway smooth muscle cell
proliferation by modulating the E2F-1/Rb pathway
1 Pulmonary, Allergy, and Critical Care Division, Department of Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104; and 2 Department of Radiation Oncology, Stritch School of Medicine, Loyola University Medical Center, Maywood, Illinois 60153
Elucidating the factors that inhibit
the increase in airway smooth muscle (ASM) mass may be of therapeutic
benefit in asthma. Here, we investigated whether interferon-
(IFN-
), a potent inducer of growth arrest in various cell types,
regulates mitogen-induced ASM cell proliferation. IFN-
(1-100
U/ml) was found to markedly decrease both DNA synthesis and ASM cell
number induced by the mitogens epidermal growth factor (EGF) and
thrombin. Interestingly, IFN-
had no effect on mitogen-induced
activation of three major mitogenic signaling pathways,
phosphatidylinositol 3-kinase, p70S6k, or mitogen-activated
protein kinases. Mitogen-induced expression of cell cycle regulator
cyclin D1 was increased by IFN-
, whereas no effect was observed on
degradation of p27Kip1. Expression array analysis of 23 cell cycle-related genes showed that IFN-
inhibited EGF-induced
increases in E2F-1 expression, whereas induction of c-myc,
cyclin D2, Egr-1, and mdm2 were unaffected. Induction of E2F-1 protein
and Rb hyperphosphorylation after mitogen stimulation was also
suppressed by IFN-
. In addition, IFN-
decreased activation of
cdk2 and expression of cyclin E, upstream signaling molecules
responsible for Rb hyperphosphorylation in the late G1 phase. IFN-
also increased levels of IFI 16 protein, whose mouse homolog p202 has
been associated with growth inhibition. Together, our data indicate
that IFN-
is an effective inhibitor of ASM cell proliferation by
blocking transition from G1-to-S phase by acting at two different
levels: modulation of cdk2/cyclin E activation and inhibition of E2F-1
gene expression.
cytokines; airway remodeling; signal transduction; airway smooth muscle hyperplasia
This article has been cited by other articles:
![]() |
M. Okamoto, K. Takeda, A. Joetham, H. Ohnishi, H. Matsuda, C. H. Swasey, B. J. Swanson, K. Yasutomo, A. Dakhama, and E. W. Gelfand Essential role of Notch signaling in effector memory CD8+ T cell-mediated airway hyperresponsiveness and inflammation J. Exp. Med., May 12, 2008; 205(5): 1087 - 1097. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Goncharova, D. A. Goncharov, A. Chisolm, M. S. Spaits, P. N. Lim, G. Cesarone, I. Khavin, O. Tliba, Y. Amrani, R. A. Panettieri Jr., et al. Interferon {beta} Augments Tuberous Sclerosis Complex 2 (TSC2)-Dependent Inhibition of TSC2-Null ELT3 and Human Lymphangioleiomyomatosis-Derived Cell Proliferation Mol. Pharmacol., March 1, 2008; 73(3): 778 - 788. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Fischer, S. Zheng, R. Fan, and J. A. Voynow Neutrophil elastase inhibition of cell cycle progression in airway epithelial cells in vitro is mediated by p27kip1 Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L762 - L768. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Koya, K. Takeda, T. Kodama, N. Miyahara, S. Matsubara, A. Balhorn, A. Joetham, A. Dakhama, and E. W. Gelfand RANTES (CCL5) Regulates Airway Responsiveness after Repeated Allergen Challenge Am. J. Respir. Cell Mol. Biol., August 1, 2006; 35(2): 147 - 154. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Wessely Interference by interferons: Janus faces in vascular proliferative diseases Cardiovasc Res, June 1, 2005; 66(3): 433 - 443. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Koga, J.-i. Suzuki, H. Kosuge, G. Haraguchi, Y. Onai, H. Futamatsu, Y. Maejima, R. Gotoh, H. Saiki, F. Tsushima, et al. Blockade of the Interaction Between PD-1 and PD-L1 Accelerates Graft Arterial Disease in Cardiac Allografts Arterioscler. Thromb. Vasc. Biol., November 1, 2004; 24(11): 2057 - 2062. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhou, J. Li, A. M. Goldsmith, D. C. Newcomb, D. M. Giannola, R. G. Vosk, E. M. Eves, M. R. Rosner, J. Solway, and M. B. Hershenson Human Bronchial Smooth Muscle Cell Lines Show a Hypertrophic Phenotype Typical of Severe Asthma Am. J. Respir. Crit. Care Med., March 15, 2004; 169(6): 703 - 711. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |